AngioDynamics Inc Stock Guidance

ANGONASDAQ
$12.79
-0.13-1.01%
At close: Jul 10, 5:00 PM EST
$12.79
N/A
After Hours: Jul 10, 4:00 PM EST

AngioDynamics (ANGO) last issued guidance on April 2, 2026 for fiscal year 2026. The company guided earnings per share in the range of $-0.30 - $-0.23, compared to a consensus EPS estimate of $-0.28. AngioDynamics also guided revenue in the range of $313.50M - $315.50M for the period.

Compared to prior guidance, AngioDynamics raised its EPS outlook from a previous range of $-0.33 - $-0.23. On the revenue side, the company maintained its revenue forecast from a prior range of $312.00M - $314.00M.

AngioDynamics has issued 18 guidance updates between July 12, 2022 and April 2, 2026. During this period, the company raised its outlook 6 times and lowered it 4 times, providing investors with insight into management's evolving expectations.

Latest Guidance Date
Apr 2, 2026
Guidance Period
Full Year 2026
EPS Guidance Range
$-0.30 - $-0.23
Revenue Guidance Range
$313.50M - $315.50M

AngioDynamics Guidance History

Review all historical guidance issued by AngioDynamics, including EPS and revenue forecasts across quarterly and annual periods.

Loading calendar...

FAQ

Q

What is the most recent guidance for AngioDynamics (ANGO)?

A

The most recent guidance for AngioDynamics (ANGO) was reported on April 2, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $-0.30 to $-0.23, compared to the estimated EPS of $-0.28. Additionally, AngioDynamics forecasted revenue between $313.50M and $315.50M for the period.

Q

What EPS range did AngioDynamics (ANGO) guide for?

A

AngioDynamics (ANGO) guided EPS in the range of $-0.30 to $-0.23 for the fiscal year 2026. The consensus analyst EPS estimate is $-0.28.

Q

What revenue range did AngioDynamics (ANGO) guide for?

A

AngioDynamics (ANGO) guided revenue in the range of $313.50M to $315.50M for the fiscal year 2026.

Q

Did AngioDynamics (ANGO) raise or lower guidance?

A

AngioDynamics (ANGO) raised its EPS guidance from a prior range of $-0.33 - $-0.23 to $-0.30 - $-0.23 for the fiscal year 2026.

Q

When did AngioDynamics (ANGO) last issue guidance?

A

AngioDynamics (ANGO) last issued guidance on April 2, 2026 for the fiscal year 2026.